Product Information
SILVER SULFADIAZINE 1% CREAM is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.2596 per GM under NDC 59762013106. Its NADAC has been published 451 times since Feb 14, 2018.
FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10 mg/g
Manufacturer
Mylan Pharmaceuticals Inc.NDC
59762013106
Classification
Generic
Dosage Form
CREAM
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
SILVER SULFADIAZINEApproval Type
Authorized Generic (NDA)
FDA Application
NDA017381FDA Approved
Before 1982
TE Code
AB
On Market Since
1/15/2018
Pharmacological Classes
Price Statistics
The NADAC for SILVER SULFADIAZINE 1% CREAM has been published 451 times since Feb 14, 2018, and over the history we have for it it has risen 54.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2596 per GM |
|---|---|
| All-time high | $0.2596 (Sep 30, 2026) |
| All-time low | $0.1114 (Jul 17, 2024) |
| 52-week high | $0.2596 |
| 52-week low | $0.2022 |
| Median price | $0.1458 |
| Average price | $0.1569 |
| Largest weekly change | +29.6% (Aug 21, 2024) |
| Weeks tracked | 451 |
| Tracking since | Feb 14, 2018 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 52% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Mylan Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
silver sulfadiazine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Sulfonamide Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of SILVER SULFADIAZINE 1% CREAM?
The current National Average Drug Acquisition Cost (NADAC) for SILVER SULFADIAZINE 1% CREAM, manufactured by Mylan Pharmaceuticals Inc., is $0.2596 per GM (NDC 59762013106), effective Sep 30, 2026.
How has the price of SILVER SULFADIAZINE 1% CREAM changed over time?
Over the history we have for it, the NADAC for SILVER SULFADIAZINE 1% CREAM has risen 54.4%. It has been tracked across 451 weekly CMS publications since Feb 14, 2018.
What are the highest and lowest recorded NADAC prices for SILVER SULFADIAZINE 1% CREAM?
Since Feb 14, 2018, the NADAC for SILVER SULFADIAZINE 1% CREAM has ranged from a low of $0.1114 (Jul 17, 2024) to a high of $0.2596 (Sep 30, 2026), with a median of $0.1458 per GM.
Are there cheaper alternatives to SILVER SULFADIAZINE 1% CREAM?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, SILVADENE 1% CREAM, is $0.1247 per GM — about 52% below SILVER SULFADIAZINE 1% CREAM.
Who manufactures SILVER SULFADIAZINE 1% CREAM?
SILVER SULFADIAZINE 1% CREAM (NDC 59762013106) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.